Development and characterization of cationic nanoemulsions as non-viral vectors for plasmid DNA delivery

被引:4
|
作者
Isar, Selen [1 ]
Akbaba, Hasan [1 ]
Erel-Akbaba, Gulsah [2 ]
Baspinar, Yucel [1 ]
机构
[1] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-35100 Izmir, Turkey
[2] Izmir Katip Celebi Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-35620 Izmir, Turkey
来源
JOURNAL OF RESEARCH IN PHARMACY | 2020年 / 24卷 / 06期
关键词
Cationic nanoemulsion; non-viral vector; pDNA; complexation; cytotoxicity; microfluidization; NONIONIC SURFACTANTS; IN-VITRO; GENE; LIPOPLEXES; SYSTEM;
D O I
10.35333/jrp.2020.255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene therapy is a promising approach to treat several diseases including cancer. Unfortunately, free nucleic acids are negatively charged and not stable in blood. Cationic drug delivery systems like cationic nanoemulsions (CNEs) are useful to improve the stability and delivery of nucleic acids like plasmid DNA (pDNA) by increasing the interaction between nucleic acids and negatively charged cell membrane. This study is focused on the development and characterization of two CNEs (CNE 1 and CNE 2) for the delivery of pDNA. The CNEs were prepared with microfluidization by investigating the homogenization duration of 1-10 minutes and the droplet size (DS), polydispersity index (PDI), zeta potential (ZP), complexation with pDNA and cytotoxicity on mouse fibroblast cells L929 were characterized. With increasing the microfluidization duration from 1 to 10 minutes, the DS and PDI decreased and the ZP increased for CNE 1, while for CNE 2 the ZP decreased too. Increasing the microfluidization duration does not lead to beneficial results, thus 1 minute seems to be sufficient for obtaining CNEs with appropriate properties. Both CNEs were able to form a complex in a ratio of 1 Al plasmid and 2 mu l CNE. The cytotoxicity studies for CNE 1 and its complex revealed that with increasing the applied dose the viability of the L929 cells decreased to 70%, while for CNE 2 and its complex the viability was reduced to 10%. Based on these results it can be stated that CNE 1 is more appropriate than CNE 2 for pDNA delivery.
引用
收藏
页码:952 / 960
页数:9
相关论文
共 50 条
  • [31] Sucrose ester based cationic liposomes as effective non-viral gene vectors for gene delivery
    Zhao, Yinan
    Zhu, Jie
    Zhou, Hengjun
    Guo, Xin
    Tian, Tian
    Cui, Shaohui
    Zhen, Yuhong
    Zhang, Shubiao
    Xu, Yuhong
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 145 : 454 - 461
  • [32] Cholesterol derived cationic lipids as potential non-viral gene delivery vectors and their serum compatibility
    Ju, Jia
    Huan, Meng-Lei
    Wan, Ning
    Hou, Yi-Lin
    Ma, Xi-Xi
    Jia, Yi-Yang
    Li, Chen
    Zhou, Si-Yuan
    Zhang, Bang-Le
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (10) : 2401 - 2407
  • [33] Non-viral charge reversal vectors for pDNA delivery
    Prata, Carla A. H.
    Li, Yougen
    Luo, Dan
    McIntosh, Thomas J.
    Grinstaff, Mark W.
    2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, 2006, : 4486 - +
  • [34] Solid lipid nanoparticles mediate non-viral delivery of plasmid DNA to dendritic cells
    Alekhya Penumarthi
    Deepti Parashar
    Amanda N. Abraham
    Chaitali Dekiwadia
    Ian Macreadie
    Ravi Shukla
    Peter M. Smooker
    Journal of Nanoparticle Research, 2017, 19
  • [35] Solid lipid nanoparticles mediate non-viral delivery of plasmid DNA to dendritic cells
    Penumarthi, Alekhya
    Parashar, Deepti
    Abraham, Amanda N.
    Dekiwadia, Chaitali
    Macreadie, Ian
    Shukla, Ravi
    Smooker, Peter M.
    JOURNAL OF NANOPARTICLE RESEARCH, 2017, 19 (06)
  • [36] Optimization of a New Non-viral Vector for Transfection: Eudragit Nanoparticles for the Delivery of a DNA Plasmid
    Gargouri, M.
    Sapin, A.
    Bouali, S.
    Becuwe, P.
    Merlin, J. L.
    Maincent, P.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (06) : 433 - 443
  • [37] Systems for gene delivery based on combination of viral and non-viral vectors
    Carlisle, RC
    Fisher, KD
    Parker, AL
    Seymour, LW
    TARGETING OF DRUGS: STRATEGIES FOR GENE CONSTRUCTS AND DELIVERY, 2000, 323 : 117 - 125
  • [38] Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
    Caffery, Breanne
    Lee, Jeoung Soo
    Alexander-Bryant, Angela A.
    NANOMATERIALS, 2019, 9 (01)
  • [39] Gene delivery systems: viral vs. non-viral vectors
    Kataoka, K
    Harashima, H
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) : 151 - 151
  • [40] Optimization of DNA Delivery to A549 Cells Utilizing Non-Viral Vectors 306
    Mustafa M Siddiq
    Lance A Parton
    Pediatric Research, 1998, 43 (Suppl 4) : 55 - 55